<?xml version='1.0' encoding='utf-8'?>
<document id="25920197"><sentence text="[Predicting pharmacokinetics of anti-cancer drug, famitinib in human using physiologically based pharmacokinetic model]."><entity charOffset="50-59" id="DDI-PubMed.25920197.s1.e0" text="famitinib" /></sentence><sentence text="This study is to establish physiologically based pharmacokinetic (PBPK) models of famitinib in rat and monkey, and then to predict the pharmacokinetics and tissue distribution of famitinib in human based on the PBPK models"><entity charOffset="82-91" id="DDI-PubMed.25920197.s2.e0" text="famitinib" /><entity charOffset="179-188" id="DDI-PubMed.25920197.s2.e1" text="famitinib" /><pair ddi="false" e1="DDI-PubMed.25920197.s2.e0" e2="DDI-PubMed.25920197.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25920197.s2.e0" e2="DDI-PubMed.25920197.s2.e1" /></sentence><sentence text=" According to published paper, previous studies and the chemical properties of famitinib predicted by ACD/ADME suite and SimCYP, the PBPK models of rat and monkey were established and optimized using GastroPlus" /><sentence text=" And then, the PBPK models were applied to predict the pharmacokinetic and tissue distribution of famitinib in human"><entity charOffset="98-107" id="DDI-PubMed.25920197.s4.e0" text="famitinib" /></sentence><sentence text=" The results showed that the PBPK models of rat and monkey can fit the observed data well, and the AUC0-∞, ratios of observed and calculated data in rat and monkey were 1" /><sentence text="00 and 0" /><sentence text="97, respectively" /><sentence text=" The AUC0-∞, ratios of observed and predicted data in human were 1" /><sentence text="63 (rat to human) and 1" /><sentence text="57 (monkey to human), respectively" /><sentence text=" The rat and monkey PBPK models of famitinib were well established, and the PBPK models were applied in predicting pharmacokinetic of famitinib in human successfully"><entity charOffset="35-44" id="DDI-PubMed.25920197.s11.e0" text="famitinib" /><entity charOffset="134-143" id="DDI-PubMed.25920197.s11.e1" text="famitinib" /><pair ddi="false" e1="DDI-PubMed.25920197.s11.e0" e2="DDI-PubMed.25920197.s11.e0" /><pair ddi="false" e1="DDI-PubMed.25920197.s11.e0" e2="DDI-PubMed.25920197.s11.e1" /></sentence><sentence text=" Hence, the PBPK model of famitinib in human could be applied in future drug-drug interaction study"><entity charOffset="26-35" id="DDI-PubMed.25920197.s12.e0" text="famitinib" /></sentence><sentence text="" /></document>